Working… Menu
Trial record 33 of 124 for:    prostate cancer AND prostate cancer screening | ( Map: United States )

Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men (PSA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00761124
Recruitment Status : Active, not recruiting
First Posted : September 29, 2008
Last Update Posted : May 7, 2019
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Jonsson Comprehensive Cancer Center

Brief Summary:

The purpose of this intervention trial is aiming to increase inform decision- making in Latino men regarding prostate cancer screening.

The investigators propose to find out how much Latino men know about the benefits and risks of prostate cancer screening and what factors influence how they decide whether or not to have screening. The investigators are also interested in learning how providing education information, both verbally and in print, about the risks and benefits of prostate cancer screening affects men's interest and knowledge.

The intervention is an interactive multi-media presentation made up of a small group of 8-10 Latino men gathered to discuss about prostate cancer, screening methods, treatment, and the controversy within the medical community regarding PSA screening. A facilitator guides the 1-hour discussion and encourages participant interaction. The effect of this intervention was tested on 1000 Latino men within Los Angeles county.

Participants were recruited from 38 community venues (churches, community center, etc.). All participants were interviewed before being randomized to receive written (control group) or oral (intervention) prostate cancer education material. All of the participants will be followed up at 6-months via a telephone interview.

The investigators hypothesize that the intervention group will have an increase knowledge of prostate cancer, will have increase communication with family, friends, and medical provider, and will have an increase rate of PSA screening compared to the control group.

Condition or disease Intervention/treatment Phase
Prostate Cancer Behavioral: Intervention Session Behavioral: Printed Material Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 1006 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: Informed Decision-Making Regarding PSA Screening
Actual Study Start Date : April 2003
Estimated Primary Completion Date : January 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Prostate Cancer

Arm Intervention/treatment
Experimental: 1
Educational small group session regarding prostate cancer
Behavioral: Intervention Session
A one-hour discussion group composed of 8-10 Latino men. The session includes an interactive, multimedia presentation led by a facilitator to guide participant interaction.

Printed material regarding general prostate cancer information provided.
Behavioral: Printed Material
General prostate cancer pamphlet

Primary Outcome Measures :
  1. Inform Decision-Making [ Time Frame: 6 months post-baseline interview ]

Secondary Outcome Measures :
  1. Prostate cancer knowledge, Receipt of PSA, and Communication with family, friends, and medical providers [ Time Frame: 6 months post-baseline interview ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   50 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Latino men
  • 50 to 70 years old
  • Not ever having prostate biopsy
  • Not ever having prostate cancer
  • Not having had a PSA test within the past 12 months
  • Not having BPH (prostate inflammation)
  • Not currently experiencing prostate problems such as pain or burning sensation during urination, blood in urine, and/or desire to urinate frequently

Exclusion Criteria:

  • Not Latino
  • Younger than 50 or older than 70 years old
  • Currently experiencing prostate problems such as pain or burning sensations while urinating, blood in urine, and/or desire to urinate frequently
  • Living outside of Los Angeles county
  • Having had a prostate biopsy
  • Having had prostate cancer previously
  • Having had a prostatectomy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00761124

Layout table for location information
United States, California
UCLA, Division of Cancer Prevention and Control Research
Los Angeles, California, United States, 90095
Sponsors and Collaborators
Jonsson Comprehensive Cancer Center
National Institutes of Health (NIH)
Layout table for investigator information
Principal Investigator: Roshan Bastani, PhD University of California, Los Angeles

Layout table for additonal information
Responsible Party: Jonsson Comprehensive Cancer Center Identifier: NCT00761124     History of Changes
Other Study ID Numbers: R01CA102486 ( U.S. NIH Grant/Contract )
10-001693 ( Other Identifier: UCLA IRB )
First Posted: September 29, 2008    Key Record Dates
Last Update Posted: May 7, 2019
Last Verified: May 2019
Keywords provided by Jonsson Comprehensive Cancer Center:
PSA screening
Prostate cancer and Latino men
Additional relevant MeSH terms:
Layout table for MeSH terms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases